New balloon treatment for blocked leg arteries tested in Real-World study
NCT ID NCT07399080
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is tracking 200 people with blocked leg arteries who are receiving a special balloon coated with the drug paclitaxel (GENOSS PCB). The balloon is inflated inside the artery to open it and release the drug, which helps prevent the artery from narrowing again. Researchers are monitoring safety and effectiveness over 12 months in a real-world setting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Paclitaxel-coated balloon (GENOSS PCB)
What this could lead to
If successful, this could confirm that the GENOSS PCB is a safe and effective option for treating blocked leg arteries, potentially improving blood flow and reducing the need for repeat procedures.
What could go wrong
This is an observational study, not a randomized trial, so results may be less definitive. The balloon uses paclitaxel, which has been linked to a small increased risk of death in some prior studies, though this remains debated.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kyung Hee University Hospital at Gangdong
Seoul, 05278, South Korea